Disc Medicine Announces Completion of Merger with Gemini
The combined company will operate as Disc Medicine and will trade on the Nasdaq Global Market under the ticker symbol “IRON”Approximately $175 million of...
Source: globenewswire.com
Page 6 - John Quisel News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from John Quisel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In John Quisel Today - Breaking & Trending Today
Disc Medicine Receives FDA Orphan Drug Designation for Bitopertin for the Treatment of Erythropoietic Protoporphyria
/PRNewswire/ -- Disc Medicine, Inc. ("Disc"), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel...
Source: prnewswire.com
Bitopertin Granted Orphan Drug Status for Erythropoietic Protoporphyria
The FDA has granted Orphan Drug designation to bitopertin for the treatment of erythropoietic protoporphyria.
Source: empr.com
Disc Medicine Initiates AURORA, a Phase 2 Clinical Study of Bitopertin in Adults with Erythropoietic Protoporphyria (EPP)
/PRNewswire/ -- Disc Medicine, a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for...
Source: prnewswire.com
Gemini enters business combination deal with Disc Medicine
Gemini Therapeutics signed an agreement to merge with Disc Medicine in an all-stock deal to create a clinical-stage biopharmaceutical firm.
Source: pharmaceutical-technology.com